About the Institute
Metamor is a partnership between Pennington Biomedical Research Center, Our Lady of the Lake Regional Medical Center, the Office of the Governor of Louisiana, Louisiana Economic Development (LED), LSU Health New Orleans School of Medicine, and Pennington Biomedical Research Foundation.
Metamor is uniquely focused on the advanced treatment of obesity and diabetes. Metamor is the first institute in the nation to offer an integrated and multidisciplinary approach to caring for individuals who suffer from these devastating diseases in a single facility at the world-renowned Pennington Biomedical Research Center in Baton Rouge, LA. Our team utilizes a variety of treatment approaches, including lifestyle interventions, drug and combination therapies, and surgical procedures performed in state-of-the-art facilities at Our Lady of the Lake Regional Medical Center.
A Partnership to Create a World-Class Institute
Combining forces to combat this increasingly present issue, Metamor provides a transdisciplinary approach to weight loss and the control of diabetes. Our Institute includes:
- Lifestyle interventions, including behavioral, dietary, and exercise approaches.
- Drug therapies, including clinical research into new medications that are effective at weight loss and controlling diabetes.
- Surgical procedures, performed in state-of-the-art facilities at Our Lady of the Lake Regional Medical Center.
- Combination therapies, that utilize surgery and drug therapy in innovative ways to maximize success.
This destination program provides an integrated care model that brings world-class research and care to those we serve, both from Louisiana and beyond.
To learn more about Metamor or to see treatment options, visit metamorinstitute.org
On-Demand - Treating Obesity to Treat Type 2 Diabetes
Access up to 10 presentations from world renowned faculty from the satellite symposium at the American Diabetes Association’s 82nd Scientific Sessions, sponsored by Pennington Biomedical Research Center and Metamor Institute. The program will review and critically assess obesity management strategies including lifestyle management, weight loss and medication strategies to address documented treatment and implementation gaps in obesity and type 2 diabetes.